Abstract:Advanced maternal age (AMA) pregnancies are rapidly increasing and are associated with aberrant trophoblast cell function, poor placentation, and unfavorable pregnancy outcomes, presumably due to premature placental senescence. SIRT1 is an NAD+-dependent deacetylase with well-known antiaging effects, but its connection with placental senescence is unreported. In this study, human term placentas and first-trimester villi were collected from AMA and normal pregnancies, and a mouse AMA model was established by cross breeding young and aged male and female C57 mice. SIRT1 expression and activity in HTR8/SVneo cells were genetically or pharmacologically manipulated. Trophoblast-specific Sirt1-knockout (KO) mouse placentas were generated by mating Elf5-Cre and Sirt1fl/fl mice. Trophoblast cell mobility was assessed with transwell invasion and wound-healing assays. SIRT1-binding proteins in HTR8/SVneo cells and human placental tissue were identified by mass spectrometry. We identified SIRT1 as the only differentially expressed sirtuin between AMA and normal placentas. It is downregulated in AMA placentas early in the placental life cycle and is barely impacted by paternal age. SIRT1 loss upregulates P53 acetylation and P21 expression and impairs trophoblast invasion and migration. Sirt1-KO mouse placentas exhibit senescence markers and morphological disruption, along with decreased fetal weight. In trophoblasts, SIRT1 interacts with vimentin, regulating its acetylation. In conclusion, SIRT1 promotes trophoblast epithelial−mesenchymal transition (EMT) to enhance invasiveness by modulating vimentin acetylation. AMA placentas are associated with premature senescence during placentation due to SIRT1 loss. Therefore, SIRT1 may be an antiaging therapeutic target for improving placental development and perinatal outcomes in AMA pregnancies.

The Sirtuin-Associated Human Senescence Program Converges on the Activation of Placenta-Specific Gene PAPPA

THE Sirt GENE FAMILY AND ITS ROLE IN REGULATION OF CELL LIFESPAN

Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.

Large-scale Chromatin Reorganization Reactivates Placenta-Specific Genes That Drive Cellular Aging

SIRT7 antagonizes human stem cell aging as a heterochromatin stabilizer

SIRT1 regulates trophoblast senescence in premature placental aging in preeclampsia

Sirt1 Is Regulated By A Ppar Gamma-Sirt1 Negative Feedback Loop Associated With Senescence

Abstract 186: Impaired Nucleocytoplasmic Shuttling and Activity of SIRT1 in Response to Ischemic Stress in the Senescent Heart

Research Progress on Sirtuins Family Members and Cell Senescence.

SIRT6 Delays Cellular Senescence by Promoting P27kip1 Ubiquitin-Proteasome Degradation.

The Role of SIRT6 Protein in Aging and Reprogramming of Human Induced Pluripotent Stem Cells.

Sirt1 Protects Subventricular Zone-Derived Neural Stem Cells from DNA Double-Strand Breaks and Contributes to Olfactory Function Maintenance in Aging Mice

Advanced Maternal Age‐associated SIRT1 Deficiency Compromises Trophoblast Epithelial−Mesenchymal Transition through an Increase in Vimentin Acetylation

The SIRT6 Activator MDL‐800 Improves Genomic Stability and Pluripotency of Old Murine‐derived Ips Cells

SIRT1 and p53, effect on cancer, senescence and beyond.

SIRT1 Ameliorates Age-Related Senescence of Mesenchymal Stem Cells Via Modulating Telomere Shelterin

Sirt1 Overexpression Antagonizes Cellular Senescence with Activated Erk/S6k1 Signaling in Human Diploid Fibroblasts

A large-scale CRISPR screen and identification of essential genes in cellular senescence bypass.

Genome-wide CRISPR activation screening in senescent cells reveals SOX5 as a driver and therapeutic target of rejuvenation

Hnrnp A1 Antagonizes Cellular Senescence and Senescence‐associated Secretory Phenotype Via Regulation of SIRT1 Mrna Stability

SIRT1 reverses senescence via enhancing autophagy and attenuates oxidative stress-induced apoptosis through promoting p53 degradation